In this episode of The Future Thought Exchange, we dive into groundbreaking research that could revolutionise how we approach ageing and healthspan. By inhibiting the pro-inflammatory cytokine IL-11, scientists have shown significant improvements in lifespan and metabolic health in animal models. We explore how this protein, when suppressed, enhances muscle strength, reduces frailty, and even extends lifespan by up to 25%. Could these findings lead to new anti-ageing therapies for humans?

Join us as we discuss the molecular pathways involved, such as mTORC1 and ERK, and the exciting role AI systems like AlphaProteo play in accelerating drug design. We also highlight the potential of combining IL-11 inhibition with other longevity therapies, offering a new frontier in ageing research.

Source material: https://www.nature.com/articles/s41586-024-07701-9

Disclaimer: While the voices you hear in The Future Thought Exchange are powered by advanced AI, they can sometimes mispronounce words, misunderstand concepts, or provide information that may not be entirely accurate. These occasional "hallucinations" are a natural part of AI-driven conversations. We recommend cross-referencing the ideas discussed with trusted sources for a complete and accurate understanding.